Loading…
GeneCopoeia provides gene cloning, expression constructs, and genome editing tools (CRISPR-Cas9 clones, stable cell lines, promoter reporters, shRNA/miRNA tools) and viral delivery systems (lentivirus, AAV). In addition to ready-made cell lines and clone collections, they offer custom cloning and gene synthesis services, qPCR arrays, luciferase assay kits, antigen microarrays, exosome solutions, and other molecular biology reagents and services. The company also supplies COVID-19 research tools, including SARS-CoV-2 plasmids, receptor-stable cell lines, pseudotyped lentiviruses, and related CRISPR/shRNA resources.
AI named GeneCopoeia in December 2025.